Nektar upgraded to Outperform at Oppenheimer ahead of rezpeg readout in June
Oppenheimer upgraded Nektar (NKTR) to Outperform from Perform with a $6 price target The firm is refreshing its model ahead of the company’s ...
IGN on MSN15d
James Bond Producers Allegedly Turned Down Christopher Nolan, Who Ended Up Making Oppenheimer Instead
Following the shock news that Amazon has taken full creative control over James Bond, with long-term 007 producers Barbara ...
Five-Star Rated Analyst Pounds the Table on AppLovin (APP) Stock After Short Seller Reports
The stock of AppLovin (APP) is down nearly 30% over the past week after multiple short sellers accused the mobile technology company of ...
Christopher Nolan's The Odyssey adds Shogun star to its massively star-studded cast, and I'm getting Oppenheimer vibes all over again
Shogun star Cosmo Jarvis has joined the cast of Christopher Nolan's The Odyssey - and I don't think the cast list is ever ...
Yahoo Finance1mon
Annovis to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference
Oppenheimer's Annual Healthcare Life Sciences ... Annovis is dedicated to addressing neurodegeneration in diseases such as AD and PD. The Company is committed to developing innovative therapies ...